Ahmed Boucharaba

[Lysophosphatidic acid: a new link between blood platelets and bone metastasis].

P. Clézardin, J. Saulnier-Blache, O. Peyruchaud, 2005, Medecine sciences : M/S.

MDA-9/Syntenin Is Essential for Factor VIIa-induced Signaling, Migration, and Metastasis in Melanoma Cells*

C. Négrier, J. Bordet, H. Boukerche, 2014, The Journal of Biological Chemistry.

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

P. Clézardin, J. Guglielmi, J. Saulnier-Blache, 2004, The Journal of clinical investigation.

Phosphorylation of Synucleins by Members of the Polo-like Kinase Family*

E. Masliah, H. Lashuel, M. Zweckstetter, 2009, The Journal of Biological Chemistry.

Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms.

A. V. van Wijnen, B. Guillet, F. Menaa, 2009, Oncology research.

The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.

P. Clézardin, J. Guglielmi, J. Bordet, 2006, Proceedings of the National Academy of Sciences of the United States of America.

MDA-9/Syntenin Is Essential for Factor VIIa-induced Signaling, Migration, and Metastasis in Melanoma Cells*

C. Négrier, J. Bordet, H. Boukerche, 2014, The Journal of Biological Chemistry.